Predicting Cognitive Decline in Multiple Sclerosis: Implications for Clinical Trial Design

被引：0
|
作者：
Rao, Stephen M.
Lee, Jar-Chi
Strober, Lauren
Simon, Jack
Fisher, Elizabeth
Rudick, Richard
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A164 / A164
页数：1
相关论文
共 50 条
  • [21] Cognitive decline in neuroinflammatory diseases: the case of multiple sclerosis
    Preziosa, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 16 - 16
  • [22] Predictors of longitudinal cognitive decline in paediatric multiple sclerosis
    MacAllister, W.
    Milazzo, M.
    Christodoulou, C.
    McLinskey, N.
    Belman, A.
    Krupp, L.
    MULTIPLE SCLEROSIS, 2006, 12 : S144 - S145
  • [23] Frequency of isolated cognitive decline in patients with multiple sclerosis
    Motyl, Jiri
    Friedova, Lucie
    Vaneckova, Manuela
    Andelova, Michaela
    Menkyova, Ingrid
    Novotna, Klara
    Dana, Horakova
    Uher, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 6 - 7
  • [24] Cognitive Leisure Activity Protects Against Cognitive Decline in Multiple Sclerosis
    Sumowski, J. F.
    Chiaravalloti, N.
    Wylie, G. R.
    Gonnella, A.
    Deluca, J.
    CLINICAL NEUROPSYCHOLOGIST, 2010, 24 (05) : 911 - 911
  • [25] Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients
    Anagnostouli, Maria
    Christidi, Foteini
    Zalonis, Ioannis
    Nikolaou, Chryssoula
    Lyrakos, Dimitrios
    Triantafyllou, Nikolaos
    Evdokimidis, Ioannis
    Kilidireas, Constantinos
    NEUROLOGICAL SCIENCES, 2015, 36 (11) : 2053 - 2060
  • [26] Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients
    Maria Anagnostouli
    Foteini Christidi
    Ioannis Zalonis
    Chryssoula Nikolaou
    Dimitrios Lyrakos
    Nikolaos Triantafyllou
    Ioannis Evdokimidis
    Constantinos Kilidireas
    Neurological Sciences, 2015, 36 : 2053 - 2060
  • [27] Study design for a pragmatic clinical trial of fatigue medications in multiple sclerosis
    Nourbakhsh, Bardia
    Revirajan, Nisha
    Waubant, Emmanuelle
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 24 - 24
  • [28] Study design for a pragmatic clinical trial of fatigue medications in multiple sclerosis
    Nourbakhsh, Bardia
    Revirajan, Nisha
    Waubant, Emmanuelle
    NEUROLOGY, 2017, 88
  • [29] Rates of longitudinal cognitive decline in multiple sclerosis: characterization with a large sample and baseline clinical predictors
    Fuchs, T.
    Wojcik, C.
    Dwyer, M.
    Pol, J.
    Jaworski, M., III
    Weinstock-Guttman, B.
    Benedict, R.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 652 - 653
  • [30] Predicting clinical progression and cognitive decline in patients with relapsing-remitting multiple sclerosis: a 6-year follow-up study
    Kania, Karolina
    Pawlak, Mikolaj A.
    Forycka, Maria
    Wilkosc-Debczynska, Monika
    Michalak, Slawomir
    Lukaszewska, Agnieszka
    Wyciszkiewicz, Aleksandra
    Wypych, Aleksandra
    Serafin, Zbigniew
    Marcinkowska, Justyna
    Kozubski, Wojciech
    Kalinowska-Lyszczarz, Alicja
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2024, 58 (02) : 176 - 184
12345